2024 : 11 : 21
Morahem Ashengroph

Morahem Ashengroph

Academic rank: Professor
ORCID:
Education: PhD.
ScopusId: 56118358600
HIndex:
Faculty: Faculty of Science
Address: Department of Biological Sciences, Faculty of Sciences University of Kurdistan Pasdaran Str., P. O. Box 416, Sanandaj, Iran.
Phone: (2493) 08733664600

Research

Title
Development and evaluation of different strategies for the clean synthesis of silver nanoparticles using Yarrowia lipolytica and their antibacterial activity
Type
JournalPaper
Keywords
Yarrowia lipolytica Silver nanoparticle Optimization Antibacterial activity
Year
2020
Journal PROCESS BIOCHEMISTRY
DOI
Researchers Erfan Mohammadi ، Morahem Ashengroph ، Farshad Darvishi

Abstract

An environment-friendly, cheap method, biogenic synthesis of silver nanoparticles (AgNPs) is interesting as compared to physical and chemical synthesis methods. The aim of the present study was to utilize the inherent capability of Yarrowia lipolytica as a novel biocatalyst for green production of AgNPs using different strategies, including growing cells, resting cells, and cell-free extracts (CFE) under optimized reaction conditions. The produced AgNPs were evaluated with UV–vis spectroscopy, field emission scanning electron microscopy, energy dispersive X-ray analysis, X-ray diffraction, and Fourier transform infrared spectrometry. In the growing cells strategy, Y. lipolytica produced spherical AgNPs under the optimized conditions, 2.5 mM of silver ions, 7.5 g/l of yeast biomass, a temperature of 30 °C, a pH of 6, and a shaking rate of 50 rpm after 48 h. The sizes and monodispersity of the AgNPs in the resting cells strategy were better than those in the other two. However, the AgNPs were produced faster in the CFE strategy. The antibacterial activity and minimal inhibitory concentration of the AgNPs against certain Gram-positive and Gram-negative bacteria were determined by the agar well diffusion and broth microdilution methods. The AgNPs had a considerable antibacterial effect compared to chloramphenicol as a broad-spectrum antibiotic.